Quick Answer
Gossamer Bio, Inc. reported Common Stock Shares Outstanding of 233.68 million shares for the year ending 2025.
- Gossamer Bio, Inc. showed an increase of +3.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Gossamer Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: 60.03 million shares | Q2 2019: 60.47 million shares | Q3 2019: 60.98 million shares | Q1 2020: 62.09 million shares | Q2 2020: 71.97 million shares | Q3 2020: 72.48 million shares | Q1 2021: 74.49 million shares | Q2 2021: 74.83 million shares | Q3 2021: 75.30 million shares | Q1 2022: 76.55 million shares | Q2 2022: 76.74 million shares | Q3 2022: 93.91 million shares | Q1 2023: 95.44 million shares | Q2 2023: 95.45 million shares | Q3 2023: 225.41 million shares | Q1 2024: 226.22 million shares | Q2 2024: 226.23 million shares | Q3 2024: 226.60 million shares | Q1 2025: 227.22 million shares | Q2 2025: 227.32 million shares | Q3 2025: 231.31 million shares.
- Over the full 8 years of available data (2018 to 2025), Gossamer Bio, Inc.'s Common Stock Shares Outstanding has grown by 2,802.3%.
- Historical annual values: Fiscal year 2025: 233.68 million shares | Fiscal year 2024: 226.60 million shares | Fiscal year 2023: 225.41 million shares | Fiscal year 2022: 94.42 million shares | Fiscal year 2021: 75.75 million shares | Fiscal year 2020: 73.87 million shares | Fiscal year 2019: 61.64 million shares | Fiscal year 2018: 8.05 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: